Gold in Cheltenham

A group of 18 children and 18 adults got together to honour the memory of a dear friend who had recently died of secondary breast cancer. During Cheltenham Gold Cup week they worked incredibly hard to bake cakes and then sold them every afternoon from 5 o’clock. They raised more than £2.400; it was a…

Details

Victoria’s Story

Victoria was diagnosed with breast cancer in November 2014 followed by a rigorous course of treatment. To celebrate a significant birthday last December she compiled a wish list of things she wants to do, including mountain climbing. She doesn’t believe in doing things by halves, so she has decided to climb the three highest mountains…

Details
secodary1st

The Rosie Conversation 2018

Bristows LLP and WILL (Women in Law London) organised the “Rosie Conversation 2018” in the week of International Women’s Day to discuss Women, Diversity and the Courts. Her Honour Judge Anne Molyneux and Her Honour Judge Melissa Clarke were joined by Professor Erika Rackley in a conversation facilitated by Alexandra Marks CBE, which ranged over…

Details
secodary1st

Shenley Chanukah Party

Rebbitzin Tanya arranged a fabulous ladies’ Chanukah party. Everyone had the chance to decorate their own piece of ceramics before enjoying some wonderful refreshments and the thrill of a raffle with a huge collection of the most amazing prizes in aid of Secondary1st.

Charlie’s Story

“I would say to anyone else in my position, that we might be incurable but we’re still important. Take time for yourself” Charlie is 39 years old and lives in Camberwell, South East London. She is a property lawyer at Winckworth Sherwood and has 3 lovely cats, Charlie was diagnosed with triple negative stage 3…

Details
secodary1st

NICE approves two new drugs

NICE (The National Institute For Health and Care Excellence) has announced that two new breast cancer drugs, palbociclib (Ibrance) and ribociclib (Kisqali), are to be made available to NHS patients in England. These have been licensed as first-line treatments for post-menopausal patients with HR positive and HER2 negative locally advanced or metastatic breast cancer and…

Details